1,414 results on '"Tybjaerg-Hansen, Anne"'
Search Results
52. Triglyceride-rich remnant lipoproteins are more atherogenic than LDL per particle: is this important?
53. Plasma apolipoprotein E levels and risk of dementia: A Mendelian randomization study of 106,562 individuals
54. Statin Eligibility for Primary Prevention of Cardiovascular Disease According to 2021 European Prevention Guidelines Compared With Other International Guidelines
55. Blood–brain barrier transcytosis genes, risk of dementia and stroke: a prospective cohort study of 74,754 individuals
56. Genetic Variation in GSTP1, Lung Function, Risk of Lung Cancer, and Mortality
57. 4 - Triglycerides, Triglyceride-Rich Lipoproteins, and High-Density Lipoprotein in Coronary Heart Disease Risk Assessment
58. A common allele on chromosome 9 associated with coronary heart disease
59. Neutrophil counts and cardiovascular disease.
60. Significance of lipids, lipoproteins, and apolipoproteins during the first 14–16 months of life.
61. Women, lipids, and atherosclerotic cardiovascular disease: a call to action from the European Atherosclerosis Society.
62. Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity
63. Plasma Concentrations of Calcium and Risk of Alzheimer Disease—Observational and Genetic Studies
64. Abstract P551: Genetic Variants in the Adenosine Triphosphate-Binding Cassette Transporter A1 and Risk of Age-Related Macular Degeneration
65. Abstract 18: Impact of Preeclampsia on Cardiovascular Risk Factors in Mothers and Newborns
66. Associations of Alzheimer Disease–Protective APOE Variants With Age-Related Macular Degeneration
67. High lipoprotein(a) as a possible cause of clinical familial hypercholesterolaemia: a prospective cohort study
68. Plasma levels of apolipoprotein E and risk of ischemic heart disease in the general population
69. Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease
70. High body mass index and cancer risk—a Mendelian randomisation study
71. The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential: A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation
72. Genetic risk of fatty liver disease and mortality in the general population: A Mendelian randomization study.
73. HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials
74. Cholesteryl Ester Transfer Protein Inhibitors and Access to the Retina in Age-Related Macular Degeneration—Reply
75. Mild-to-Moderate Kidney Dysfunction and Cardiovascular Disease: Observational and Mendelian Randomization Analyses
76. Physical activity in leisure time and at work and risk of dementia: A prospective cohort study of 117,616 individuals
77. Blood Leukocyte Counts in Alzheimer Disease
78. Variants in theGPR146Gene Are Associated With a Favorable Cardiometabolic Risk Profile
79. Absolute 10-year risk of dementia by age, sex and APOE genotype: a population-based cohort study
80. Observational and genetic studies of C‐reactive protein levels and risk of Alzheimer's disease
81. Using Polygenic Hazard Scores to Predict Age at Onset of Alzheimer’s Disease in Nordic Populations
82. Pharmacogenetics-guided CETP inhibition: an open question?
83. Statin Eligibility for Primary Prevention of Cardiovascular Disease According to 2021 European Prevention Guidelines Compared With Other International Guidelines
84. Impact of diet on ten-year absolute cardiovascular risk in a prospective cohort of 94 321 individuals: A tool for implementation of healthy diets
85. Macular Degeneration and CETP Inhibition—Reply
86. The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management
87. Naturally Occurring Variants in LRP1 (Low-Density Lipoprotein Receptor–Related Protein 1) Affect HDL (High-Density Lipoprotein) Metabolism Through ABCA1 (ATP-Binding Cassette A1) and SR-B1 (Scavenger Receptor Class B Type 1) in Humans
88. APOC3 Loss-of-Function Mutations, Remnant Cholesterol, Low-Density Lipoprotein Cholesterol, and Cardiovascular Risk: Mediation- and Meta-Analyses of 137 895 Individuals
89. Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity
90. Using genetics to explore whether the cholesterol-lowering drug ezetimibe may cause an increased risk of cancer
91. Abstract 20818: Liver Fat Content, NAFLD, and Ischemic Heart Disease: Mendelian Randomization and Meta-Analysis of 279,013 Individuals
92. Abstract 19762: High LDL Cholesterol Levels and Risk of Peripheral Vascular Diseases - A Mendelian Randomization Study Including 106,548 Individuals From the General Population
93. Abstract 19755: Statin Treatment, Genetic Inhibition of HMGCR, and Risk of Symptomatic Gallstone Disease
94. Abstract 15369: Low Ldl-Cholesterol by Pcsk9 Variation and Mortality in 109,800 Individuals From the General Population
95. Genetic variation in clusterin and risk of dementia and ischemic vascular disease in the general population: cohort studies and meta-analyses of 362,338 individuals
96. Secretory Phospholipase A2-IIA and Cardiovascular Disease: A Mendelian Randomization Study
97. Reply to “Mendelian randomization highlights causal association between genetically increased C‐reactive protein levels and reduced Alzheimer's disease risk”
98. The Sialylation Pathway and Coronary Artery Disease
99. Association of plasma uric acid with ischaemic heart disease and blood pressure: mendelian randomisation analysis of two large cohorts
100. Effect of APOE ε Genotype on Lipoprotein(a) and the Associated Risk of Myocardial Infarction and Aortic Valve Stenosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.